Dexmedetomidine-based Sedation in Neurocritical Care Patients

NCT02252523 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Acute Brain Injuries

Interventions

DRUG: Dexmedetomidine

Sponsor

University Hospital, Clermont-Ferrand

Collaborators

[object Object]